Further, our results illustrated that SDS-203 treatment failed to overexpress LC3-II and LAMP-1 expression in transiently mTORC1 upregulated pancreatic cancer cells compared to control (Fig. 6D–G). This evidence concerns the gene LAMP1 and pancreatic neoplasm.